DOHA: In a significant step to further strengthen Qatar’s position in healthcare innovation, the Department of Laboratory ...

MyOme, a leading genomics innovation company, today announced the expansion of its rare disease test to include tandem repeat expansions (TREs) and mitochondrial genome analyses. Both analyses come ...

For years, a rare form of male infertility, in which men are born without the tubes that carry sperm, was blamed on a single gene tied to cyst.

A pivotal development came with the FDA approval of Caris’s MI Cancer Seek platform, the first diagnostic to combine whole ...

Rare pathogenic variants in cancer predisposition genes increase the risk of developing single and multiple primary cancers, researchers found.

A new genetic test developed at Mayo Clinic is redefining how clinicians diagnose and manage hereditary pancreatitis.

The Department of Laboratory Medicine and Pathology (DLMP) at Hamad Medical Corporation (HMC) has launched Whole Exome Sequencing (WES) testing, enhancing genetic diagnostic capabilities in Qatar. The ...

This study demonstrates that NGS-MSI is noninferior to IHC-MMR and can identify MSI-H tumors that IHC-MMR is unable to detect and conversely IHC-MMR can identify MMRd tumors that NGS-MSI misses. This ...

Here is our list of the 11 best-performing biotech stocks so far in 2025.